Table 4.
OCT measurements of the treated and the fellow eyes (values in μm)
Subject No. | Baseline of the study eye | 1 Year study eye | Baseline fellow eye | 1 Year fellow eye | |
---|---|---|---|---|---|
1 | CMT | 81 | 78 | 109 | 87 |
CCT | 235 | 257 | 374 | 248 | |
2 | CMT | 100 | 83 | 105 | 78 |
CCT | 266 | 237 | 269 | 227 | |
3 | CMT | 163 | 171 | 185 | 138 |
CCT | 203 | 199 | 242 | 180 | |
4 | CMT | 74 | 70 | 85 | 83 |
CCT | 286 | 290 | 313 | 220 | |
5 | CMT | 131 | 137 | 190 | 131 |
CCT | 195 | 242 | 238 | 227 | |
6 | CMT | 20 | 19 | 17 | 15 |
CCT | 128 | 122 | 130 | 105 | |
7 | CMT | 23 | 27 | 90 | 83 |
CCT | 190 | 183 | 322 | 302 | |
8 | CMT | 104 | 98 | 124 | 98 |
CCT | 330 | 219 | 424 | 384 |
CMT: Central macular thickness; CCT: Central choroidal thickness.
The numbers written in italics belong to the patients who experienced decrease during the follow-up period. The numbers written in bold represent the patients who had increase in CCT.